查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2020277

呼吸道管理设备市场规模、份额、成长及全球产业分析：按类型、应用和地区分類的洞察，2026-2034 年预测

Airway Management Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 126 Pages | 商品交期: 请询问到货日

价格

呼吸道管理设备市场的成长要素

全球呼吸道管理设备市场预计在2025年达到21.3亿美元，2026年增长至22.3亿美元，并在2034年达到32.5亿美元，预测期内（2026-2034年）复合年增长率为4.85%。北美地区在2025年占据市场主导地位，市占率达47.1%，这主要得益于其高额的研发投入和先呼吸道管理技术的应用。

呼吸道管理设备，例如球囊面罩、气管插管和喉镜，在气道阻塞患者的通气和呼吸功能恢復中发挥着至关重要的作用。慢性阻塞性肺病（COPD）、癌症和慢性肺病等慢性疾病的盛行率不断上升，显着推动了对这些设备的需求。根据美国国家生物技术资讯中心（NCBI，2022）的数据显示，全球40岁及以上人群中COPD的患病率约为10.1%；而美国肺臟协会（2020）报告称，美国有1250万成年人（占总人口的5%）被诊断患有COPD、慢性支气管炎或肺气肿死亡，其中5121484人死亡。

慢性病盛行率的上升也导致全球急诊和重症监护住院人数的增加。根据美国疾病管制与预防中心（CDC）2022年的数据，美国有1,620万急诊病患住院治疗，其中230万人需要重症监护。急诊和住院人数的激增，加上外科手术和麻醉治疗的增加，正在推动呼吸道管理设备的应用。

市场趋势

随着早产儿数量的增加，呼吸道管理设备的使用，尤其是在新生儿中的使用，正在不断扩大。根据世界卫生组织（WHO）2023年的报告，全球约有1,340万早产儿，占所有新生儿的10%以上。在美国，根据美国疾病管制与预防中心（CDC）2022年的数据，每十个新生儿中就有一个是早产儿，且2020年至2021年间早产率上升了4%。早产儿常出现呼吸窘迫，因此对呼吸道管理的需求也随之增加。美敦力公司的SonarMed系统等先进的儿童设备可即时监测气管插管的位置，从而减少意外拔管等併发症，并改善治疗效果。

市场成长要素

合资企业、Start-Ups以及主要产业参与者的研发投入进一步推动了这个市场的发展。美敦力、ICU Medical 和 Teleflex Incorporated 等公司正在扩大产能，并将创新医疗设备推向市场。例如，ICU Medical 于 2022 年收购 Smiths Medical，扩展了其在呼吸道管理和输液设备产品系列。此外，LifeMech 的 A-VS 復苏设备于 2020 年获得 FDA核准，为 COVID-19 疫情期间的紧急呼吸护理提供了支持。预计对这类技术先进设备的投资将推动新兴市场的成长。

市场限制

儘管需求不断增长，但医疗设备使用相关的併发症可能会限制其普及。插管呼吸道管理医疗设备有逆流、误吸、血管压迫、创伤和神经损伤等风险。根据美国国家生物技术资讯中心（NCBI，2021）统计，全球气管切开术出血发生率为0.6%至5%；NCBI（2023）报告称，与气道装置相关的心血管不稳定、低氧血症和心臟麻痹率分别为42.6%、9.3%和3.1%。儿童喉罩也可能导致软组织损伤、呕吐和气道狭窄，因此其使用需谨慎考虑。

市场区隔

按类型：

  • 到2026年，声门下呼吸道管理装置将以55.46%的市场份额引领市场，这主要得益于慢性呼吸系统疾病盛行率的上升及其在重症监护室（ICU）中的应用。诸如内建摄影机的Ambu VivaSight 2双腔支气管导管等创新产品将提升临床效率。
  • 另一方面，由于对一次性医疗器材的投资增加，因此声门上器械的复合年增长率预计将更高。

用途：

  • 预计到 2026 年，麻醉将占市场份额的 59.07%，到 2025 年，市场规模将达到 12.613 亿美元，这主要得益于外科手术数量的增加。
  • 由于医院就诊量和创伤病例的增加，预计急诊医学将呈现更高的成长率。

按最终用户划分：

  • 预计到 2026 年，医院和门诊手术中心 (ASC) 将占市场份额的 78.56%。
  • 居家医疗正在扩展，尤其是在新冠肺炎疫情后，患有慢性呼吸系统疾病的老年人数量增加的情况下。

区域趋势

  • 北美：预计到2025年将达到10.1亿美元，到2026年将达到10.5亿美元，主要受新产品发布和合作关係的推动。美国市场：8.4亿美元（2026年）。
  • 欧洲：6.7亿美元（2025年），7.1亿美元（2026年），年复合成长率5.6%。英国：5000万美元，德国：1.9亿美元（2026年）。
  • 亚太地区：2025 年为 3 亿美元，2026 年为 3.1 亿美元，在中国和印度的推动下，复合年增长率较高。
  • 拉丁美洲：1亿美元（2025-2026年）。
  • 中东和非洲：5000万美元至6000万美元（2025-2026年）。

主要企业及趋势

主要企业包括美敦力（爱尔兰）、泰利福医疗（美国）、卡尔史托斯（德国）、ICU Medical（美国）、康维泰克（英国）、安布公司（丹麦）和英特斯卡公司（英国）。近期发展如下：

  • 2023年6月：Morf Nazar面具发表。
  • 2022 年 1 月：Intersurgical Ltd 收购 Pulmodyne，扩大了在企业发展。
  • 2021年5月：Teleflex收购非侵入性通气产品。
  • 2021年3月：康维泰克收购Cure Medical。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 2025/2025年主要国家及地区慢性阻塞性肺病（COPD）盛行率
  • 主要国家气喘盛行率，2025/2025
  • 新产品发布：按主要企业划分
  • 产业主要趋势：主要企业的合併、联盟和收购。
  • 新冠疫情的影响：全球呼吸道管理设备市场

第五章：全球呼吸道管理设备市场分析、洞察与预测（2021-2034年）

  • 市场分析、洞察与预测：按类型
    • 声门下呼吸道管理装置
      • 气切管
      • 气管插管（ETTS）
    • 声门上呼吸道管理装置
      • 口嚥气道（OPAS）
      • 喉罩方形路（LMAS）
      • 鼻嚥气道
    • 喉镜
    • 其他的
  • 市场分析、洞察与预测：按应用领域划分
    • 麻醉
    • 紧急医疗护理
    • 其他的
  • 市场分析、洞察与预测：按最终用户划分
    • 医院和门诊手术中心（ASC）
    • 居家医疗
    • 其他的
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美呼吸道管理设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲呼吸道管理设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 英国
    • 其他欧洲国家

第八章：亚太地区呼吸道管理设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 中国
    • 印度
    • 东南亚
    • 日本
    • 澳洲
    • 其他亚太国家

第九章：拉丁美洲呼吸道管理设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东和非洲呼吸道管理设备市场分析、洞察与预测（2021-2034年）

  • 国家
    • GCC
    • 南非
    • 其他中东和非洲国家

第十一章 竞争分析

  • 全球市占率分析（2025 年）
  • 公司简介
    • Medtronic
    • Teleflex Incorporated
    • KARL STORZ SE & Co. KG
    • ICU Medical
    • Convatec Inc.
    • Ambu A/S
    • Intersurgical Ltd
    • VBM Medizintechnik GmbH
    • VYAIRE MEDICAL, INC.
    • Flexicare（Group）Limited
Product Code: FBI107396

Growth Factors of airway management devices Market

The global airway management devices market was valued at USD 2.13 billion in 2025 and is projected to grow to USD 2.23 billion in 2026, reaching USD 3.25 billion by 2034, reflecting a CAGR of 4.85% during the forecast period (2026-2034). North America dominated the market with a 47.1% share in 2025, driven by high R&D investments and the launch of advanced airway management technologies.

Airway management devices, including bag-valve masks, endotracheal tubes, and laryngoscopes, play a critical role in providing ventilation and restoring breathing in patients with airway obstruction. The rising prevalence of chronic conditions such as COPD, cancer, and chronic lung diseases has significantly contributed to the demand for these devices. According to the National Center for Biotechnology Information (NCBI, 2022), the global prevalence of COPD among people aged 40 and above is around 10.1%, while the American Lung Association (2020) reported that 12.5 million U.S. adults (5% of the population) were diagnosed with COPD, chronic bronchitis, or emphysema, with 148,512 deaths recorded due to COPD.

The increase in chronic disease prevalence has also amplified emergency and intensive care admissions globally. In the U.S., CDC data (2022) shows 16.2 million emergency department visits resulted in hospital admissions, with 2.3 million requiring critical care. This surge in emergency and inpatient care, coupled with rising surgical procedures and anesthetic interventions, has driven the adoption of airway management devices.

Market Trends

The adoption of airway management devices is particularly increasing among neonates, due to the rise in premature births. The WHO (2023) reported approximately 13.4 million premature births worldwide in 2020, representing more than 10% of all births. In the U.S., CDC (2022) data indicates 1 in 10 births is preterm, with a 4% increase in preterm birth rate from 2020 to 2021. Premature infants frequently experience breathing disorders, increasing the need for airway management. Advanced pediatric devices, such as Medtronic's SonarMed system, allow real-time monitoring of endotracheal tube positioning, reducing complications like unplanned extubations and improving outcomes.

Market Growth Factors

The market is further bolstered by joint ventures, start-ups, and R&D investments by key industry players. Companies like Medtronic, ICU Medical, and Teleflex Incorporated are expanding production capabilities and launching innovative devices. For example, ICU Medical's acquisition of Smiths Medical in 2022 expanded its portfolio in airway management and infusion devices, while LifeMech's A-VS resuscitator received FDA approval in 2020, supporting emergency respiratory care during COVID-19. These investments in technologically advanced devices are anticipated to propel market growth across emerging nations.

Market Restraints

Despite growing demand, complications associated with device use can limit adoption. Intubation and airway devices carry risks such as regurgitation, aspiration, vascular compression, trauma, and nerve injury. According to NCBI (2021), tracheostomy bleeding occurs in 0.6-5% of cases globally, and NCBI (2023) reports cardiovascular instability, hypoxemia, and cardiac arrest rates of 42.6%, 9.3%, and 3.1%, respectively, linked to airway devices. Pediatric laryngeal masks may also cause soft-tissue trauma, vomiting, and airway restriction, highlighting the need for cautious usage.

Market Segmentation

By Type:

  • Infraglottic airway management devices led the market with 55.46% share in 2026, driven by chronic respiratory disease prevalence and ICU usage. Innovations such as Ambu VivaSight 2 DLT with a built-in camera enhance clinical efficiency.
  • Supraglottic devices are projected to grow at a higher CAGR due to rising investments in single-use devices.

By Application:

  • Anesthesia dominates with 59.07% share in 2026, generating USD 1,261.3 million in 2025, fueled by increasing surgical procedures.
  • Emergency medicine is projected to register higher growth due to rising hospital visits and trauma incidents.

By End-User:

  • Hospitals & ASCs accounted for 78.56% share in 2026.
  • Homecare is expanding due to increasing geriatric populations with chronic respiratory conditions, particularly post-COVID-19.

Regional Insights

  • North America: USD 1.01 billion (2025), projected USD 1.05 billion (2026), driven by new device launches and collaborations. U.S. market: USD 0.84 billion (2026).
  • Europe: USD 0.67 billion (2025), USD 0.71 billion (2026), CAGR 5.6%. UK: USD 0.05 billion; Germany: USD 0.19 billion (2026).
  • Asia Pacific: USD 0.3 billion (2025), USD 0.31 billion (2026), strong CAGR, led by China and India.
  • Latin America: USD 0.1 billion (2025-2026).
  • Middle East & Africa: USD 0.05-0.06 billion (2025-2026).

Key Companies & Developments

Prominent players include Medtronic (Ireland), Teleflex Incorporated (U.S.), KARL STORZ (Germany), ICU Medical (U.S.), Convatec (U.K.), Ambu A/S (Denmark), and Intersurgical Ltd (U.K.). Recent developments include:

  • June 2023: Morf Nasal Mask launch.
  • Jan 2022: Intersurgical's acquisition of Pulmodyne, expanding U.S. and global reach.
  • May 2021: Teleflex acquisition of non-invasive ventilation products.
  • March 2021: Convatec acquisition of Cure Medical.

Conclusion

The global airway management devices market is poised for steady growth, driven by rising chronic respiratory disorders, increasing surgical and emergency procedures, technological advancements, and expanding applications in neonatal care. While complications associated with device usage remain a restraint, strategic investments, product innovations, and regional expansion efforts by key players are expected to propel the market to USD 3.25 billion by 2034.

Segmentation By Type

  • Infraglottic Airway Management Devices
    • Endotracheal Tubes
    • Tracheostomy Tubes
  • Supraglottic Airway Management Devices
    • Oropharyngeal Airways (OPAS)
    • Laryngeal Mask Airways (LMAS)
    • Nasopharyngeal Airways
  • Laryngoscopes
  • Others

By Application

  • Anesthesia
  • Emergency Medicine
  • Others

By End User

  • Hospitals & ASCs
  • Home care
  • Others

By Region

  • North America (By Type, Application, End User and Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Type, By Application, End User and Country/Sub-Region)
    • Germany (By Application)
    • France (By Application)
    • U.K. (By Application)
    • Spain (By Application)
    • Italy (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Type, Application, End User and Country/Sub-Region)
    • China (By Application)
    • India (By Application)
    • Southeast Asia (By Application)
    • Japan (By Application)
    • Australia (By Application)
    • Rest of Asia Pacific (By Application)
  • Latin America (By Type, Application, End User and Country/Sub-Region)
    • Mexico (By Application)
    • Brazil (By Application)
    • Rest of Latin America (By Application)
  • Middle East & Africa (By Type, End User, and Country/Sub-Region)
    • GCC (By Application)
    • South Africa (By Application)
    • Rest of MEA (By Application)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Chronic Obstructive Pulmonary Disease, By Key Countries/Sub-Region, 2025/2025
  • 4.2. Prevalence of Asthma, By Key Countries, 2025/2025
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments: Mergers, Partnerships, & Acquisitions, By Key Players
  • 4.5. Impact of COVID-19 on Global Airway Management Devices Market

5. Global Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Infraglottic Airway Management Devices
      • 5.1.1.1. Tracheostomy Tubes
      • 5.1.1.2. Endotracheal Tubes (ETTS)
    • 5.1.2. Supraglottic Airway Management Devices
      • 5.1.2.1. Oropharyngeal Airways (OPAS)
      • 5.1.2.2. Laryngeal Mask Airways (LMAS)
      • 5.1.2.3. Nasopharyngeal Airways
    • 5.1.3. Laryngoscopes
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Anesthesia
    • 5.2.2. Emergency Medicine
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Home Care
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Infraglottic Airway Management Devices
      • 6.1.1.1. Tracheostomy Tubes
      • 6.1.1.2. Endotracheal Tubes (ETTS)
    • 6.1.2. Supraglottic Airway Management Devices
      • 6.1.2.1. Oropharyngeal Airways (OPAS)
      • 6.1.2.2. Laryngeal Mask Airways (LMAS)
      • 6.1.2.3. Nasopharyngeal Airways
    • 6.1.3. Laryngoscopes
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Anesthesia
    • 6.2.2. Emergency Medicine
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Home Care
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
      • 6.4.1.1. By Application
    • 6.4.2. Canada
      • 6.4.2.1. By Application

7. Europe Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Infraglottic Airway Management Devices
      • 7.1.1.1. Tracheostomy Tubes
      • 7.1.1.2. Endotracheal Tubes (ETTS)
    • 7.1.2. Supraglottic Airway Management Devices
      • 7.1.2.1. Oropharyngeal Airways (OPAS)
      • 7.1.2.2. Laryngeal Mask Airways (LMAS)
      • 7.1.2.3. Nasopharyngeal Airways
    • 7.1.3. Laryngoscopes
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Anesthesia
    • 7.2.2. Emergency Medicine
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Home Care
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
      • 7.4.1.1. By Application
    • 7.4.2. Spain
      • 7.4.2.1. By Application
    • 7.4.3. France
      • 7.4.3.1. By Application
    • 7.4.4. Italy
      • 7.4.4.1. By Application
    • 7.4.5. U.K.
      • 7.4.5.1. By Application
    • 7.4.6. Rest of Europe
      • 7.4.6.1. By Application

8. Asia Pacific Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Infraglottic Airway Management Devices
      • 8.1.1.1. Tracheostomy Tubes
      • 8.1.1.2. Endotracheal Tubes (ETTS)
    • 8.1.2. Supraglottic Airway Management Devices
      • 8.1.2.1. Oropharyngeal Airways (OPAS)
      • 8.1.2.2. Laryngeal Mask Airways (LMAS)
      • 8.1.2.3. Nasopharyngeal Airways
    • 8.1.3. Laryngoscopes
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Anesthesia
    • 8.2.2. Emergency Medicine
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Home Care
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
      • 8.4.1.1. By Application
    • 8.4.2. India
      • 8.4.2.1. By Application
    • 8.4.3. Southeast Asia
      • 8.4.3.1. By Application
    • 8.4.4. Japan
      • 8.4.4.1. By Application
    • 8.4.5. Australia
      • 8.4.5.1. By Application
    • 8.4.6. Rest of Asia Pacific
      • 8.4.6.1. By Application

9. Latin America Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Infraglottic Airway Management Devices
      • 9.1.1.1. Tracheostomy Tubes
      • 9.1.1.2. Endotracheal Tubes (ETTS)
    • 9.1.2. Supraglottic Airway Management Devices
      • 9.1.2.1. Oropharyngeal Airways (OPAS)
      • 9.1.2.2. Laryngeal Mask Airways (LMAS)
      • 9.1.2.3. Nasopharyngeal Airways
    • 9.1.3. Laryngoscopes
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Anesthesia
    • 9.2.2. Emergency Medicine
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Home Care
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
      • 9.4.1.1. By Application
    • 9.4.2. Mexico
      • 9.4.2.1. By Application
    • 9.4.3. Rest of Latin America
      • 9.4.3.1. By Application

10. Middle East & Africa Airway Management Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Type
    • 10.1.1. Infraglottic Airway Management Devices
      • 10.1.1.1. Tracheostomy Tubes
      • 10.1.1.2. Endotracheal Tubes (ETTS)
    • 10.1.2. Supraglottic Airway Management Devices
      • 10.1.2.1. Oropharyngeal Airways (OPAS)
      • 10.1.2.2. Laryngeal Mask Airways (LMAS)
      • 10.1.2.3. Nasopharyngeal Airways
    • 10.1.3. Laryngoscopes
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Anesthesia
    • 10.2.2. Emergency Medicine
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Home Care
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
      • 10.4.1.1. By Application
    • 10.4.2. South Africa
      • 10.4.2.1. By Application
    • 10.4.3. Rest of Middle East & Africa
      • 10.4.3.1. By Application

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Medtronic
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Teleflex Incorporated
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. KARL STORZ SE & Co. KG
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. ICU Medical
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Convatec Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Ambu A/S
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Intersurgical Ltd
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. VBM Medizintechnik GmbH
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. VYAIRE MEDICAL, INC.
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Flexicare (Group) Limited
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 02: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices Type, 2021-2034
  • Table 03: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices Type, 2021-2034
  • Table 04: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 05: Global Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 06: Global Airway Management Devices Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 07: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 08: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices, 2021-2034
  • Table 09: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices, 2021-2034
  • Table 10: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 11: North America Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 12: North America Airway Management Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: U.S. Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: Canada Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 15: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 16: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices, 2021-2034
  • Table 17: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices, 2021-2034
  • Table 18: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 21: Germany Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Spain Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: France Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Italy Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 25: U.K. Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 26: Rest of Europe Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 28: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices, 2021-2034
  • Table 29: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices, 2021-2034
  • Table 30: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 31: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 32: Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 33: China Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: India Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 35: Southeast Asia Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 36: Japan Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 37: Australia Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 38: Rest of Asia Pacific Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 39: Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 40: Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 41: Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 42: Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 43: Brazil Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 44: Mexico Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 45: Rest of Latin America Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 46: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 47: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Infraglottic Airway Management Devices, 2021-2034
  • Table 48: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Supraglottic Airway Management Devices, 2021-2034
  • Table 49: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 50: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 51: Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034
  • Table 52: GCC Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 53: South Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 54: Rest of Middle East & Africa Airway Management Devices Market Revenue (USD billion) Forecast, By Application, 2021-2034

List of Figures

  • Figure 01: Global Airway Management Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 02: Global Airway Management Devices Market Value Share (%), By Type, 2025 & 2034
  • Figure 03: Global Airway Management Devices Market Value Share (%), By Application, 2025 & 2034
  • Figure 04: Global Airway Management Devices Market Value Share (%), By End User, 2025 & 2034
  • Figure 05: Global Airway Management Devices Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 07: North America Airway Management Devices Market Value Share (%), by Type, 2025
  • Figure 08: North America Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 09: North America Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 10: North America Airway Management Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 11: North America Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 12: North America Airway Management Devices Market Value (USD billion), by Country, 2025 & 2034
  • Figure 13: North America Airway Management Devices Market Value Share (%), by Country, 2025
  • Figure 14: Europe Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 15: Europe Airway Management Devices Market Value Share (%), by Type, 2025
  • Figure 16: Europe Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 18: Europe Airway Management devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 19: Europe Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 20: Europe Airway Management Devices Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 21: Europe Airway Management Devices Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 22: Asia Pacific Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 23: Asia Pacific Airway Management Devices Market Value Share (%),
  • Figure 24: Asia Pacific Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Airway Management devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 27: Asia Pacific Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 28: Asia Pacific Airway Management Devices Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 29: Asia Pacific Airway Management Devices Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 30: Latin America Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 31: Latin America Airway Management Devices Market Value Share (%), by Type, 2025
  • Figure 32: Latin America Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 34: Latin America Airway Management Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 35: Latin America Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 36: Latin America Airway Management Devices Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034
  • Figure 37: Latin America Airway Management Devices Market Value Share (%), by Country/ Sub-Region, 2025
  • Figure 38: Middle East & Africa Airway Management Devices Market Value (USD billion), by Type, 2025 & 2034
  • Figure 39: Middle East & Africa Airway Management Devices Market Value Share (%), by Type, 2025
  • Figure 40: Middle East & Africa Airway Management Devices Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Airway Management Devices Market Value Share (%), by Application, 2025
  • Figure 42: Middle East & Africa Airway Management Devices Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Middle East & Africa Airway Management Devices Market Value Share (%), by End User, 2025
  • Figure 44: Middle East & Africa Airway Management Devices Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034
  • Figure 45: Middle East & Africa Airway Management Devices Market Value Share (%), by Country/ Sub-Region, 2025
  • Figure 46: Global Airway Management Devices Market Share Analysis (%), By Company, 2025